期刊文献+

HbA1c、血小板活化标志物在糖尿病及其并发症诊断和监测中的作用 被引量:6

Roles of HbA1c and Platelet Activation Markers Detection in the Diagnosis and Monitoring of Diabetes and Its Complications
暂未订购
导出
摘要 目的检测糖尿病及其并发症患者糖化血红蛋白及血小板活化标志物CD62P,PAC-1,TXB2的含量,探讨这些指标与糖尿病及其并发症的关系,阐明糖化血红蛋白及血小板活化标志物在糖尿病并发症的诊断及监测中的作用.方法选择糖尿病患者50例(单纯糖尿病20例,糖尿病并发症30例),正常对照50例,分别检测糖化血红蛋白(HbA1c),CD62P,PAC-1及TXB2等生化指标,并进行统计学分析.结果单纯糖尿病组、糖尿病并发症组及正常对照组HbA1c的浓度分别是(6.81±1.12)%,(7.77±1.31)%及(3.0±0.39)%,单纯糖尿病组及糖尿病并发症组的HbA1c浓度明显高于正常对照组;单纯糖尿病组及糖尿病并发症组的CD62P,PAC-1及TXB2水平也明显高于正常对照组,且糖尿病并发症组的上述血小板活化标志物指标高于单纯糖尿病组.结论HbA1c、血小板活化标志物对糖尿病及其并发症的诊断具有重要的作用,监测血小板活化标志物的变化可预测糖尿病并发症的发生、发展,对于早期防治糖尿病并发症具有重要意义. Objective To measure HbAlc levels and platelet activation markers CD62P, PAC-1 and TXB2 levels and explore the correlation of the indexes with diabetes and its complications to illustrate the roles of HbAlc and platelet activation markers detection in the diagnosis and monitoring of diabetes and its complications. Method 50 patients with diabetes (20 simple diabetes and 30 cases of diabetes with complications) and 50 non-diabetic subjects as control were enrolled. HbA1c, CD62P, PAC-1 and TXB2 were detected, and the results were compared and analyzed statistically. Results HbAlc contents in the simple diabetes group, diabetes complication group and normal control group were ( 6.81 ± 1.12 ) %, ( 7.77 ± 1.31 ) % and(3.0±0.39)% respectively. HbA1c contents in the simple diabetes group and diabetes complication group were significantly higher than those in the normal control group; CD62P ,PAC-1 and TXB2 levels in the simple diabetes group and diabetes complication group were also significantly higher than those in the normal control group. Conclusion The detection of HbA1c and platelet activation markers levels should be significant to the diagnosis of diabetes and its complications. The change in platelet activation markers level may be used to predict the occurrence and development of diabetes and its complications, it is of important significance to the early prevention and treatment of diabetes complications.
出处 《北华大学学报(自然科学版)》 CAS 2014年第3期338-341,共4页 Journal of Beihua University(Natural Science)
基金 国家级大学生创新性实验计划项目(201210201025)
关键词 糖化血红蛋白 CD62P PAC-1 TXB2 Glycosylated hemoglobin ( HbA1c ) CD62 P PAC-1 TXB2
  • 相关文献

参考文献23

二级参考文献68

共引文献181

同被引文献55

  • 1Bonnet F, Empana JP, Natali A, et al. Elevated heart rate predicts βcell function in non-diabetic individuals: the RISC cohort[J]. Eur JEndocrinol, 2015, 173(3): 409-415.
  • 2Merovci A, Mari A, Solis C, et al. Dapagliflozin lowers plasmaglucose concentration and improves β-cell function[J]. J ClinEndocrinol Metab, 2015, 100(5): 1927-1932.
  • 3DAVI G,CIABATTONI G,CONSOLI A,et al.In vivo forma- tion of 8-iso-prostaglandin F2alpha and platelet activation in di- abetes mellitus:effectsof improved metabolic control and vitamin E supplementation[J].Circulation,1999,99(2);224-229.
  • 4PEREG D,BERLIN T,MOSSERIM.Mean platelet volume on admission correlates with impairedresponse to thrombolysis in patients with ST-elevationmyocardial infarction[J].Platelets,2010,21(2):117-121.
  • 5ARSLAN MS,TOPALOGLU 0,SAHIN M,et al.Preclinical atherosclerosis in patients with prolactinoma[J].EndocrPract,2014,20(5):447-451.
  • 6GONCALVES LH,DUSSE LM,FERNANDES AP,et al.Uri- nary 11- dehydro thromboxane B levels in type 2 diabetic patients before and during aspirin intake[J].Clin Chim Acta,2011,412(15):1366-1370.
  • 7Summary of the 2007 European Society of Hypertension(ESH)and European Society of Cardiology(ESC)guidelines for the management of arterial hypertension[J].Vasc Health Risk Man- ag,2007,3(6):783-795.
  • 8MONTALESCOT G,SECHTEM U,ACHENBACH S,et al.2013 ESC guidelines on the managementof stable coronary artery disease:the Task Force on the management of stablecoronary artery disease of the European Society of Cardiology[J].Eur Heart J,2013,34(38):2949-3003.
  • 9ELSHERBINY IA,SHOUKRY A,EL TAHLAWI MA.Mean platelet volume and its relation to insulinresistance in non-dia- betic patients with slow coronary flow[J].J Cardiol,2012,59(2):176-181.
  • 10HAN JY,CHOI DH,CHOI SW,et al.Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus[J].Platelets,2013,24(5):401-406.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部